COMMUNIQUÉS West-GlobeNewswire

Corium Prices Offering of $100 Million of 5% Convertible Senior Notes
01/03/2018
MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
GTX Corp Launches $99.00 Easy Start Plan for GPS SmartSole® and Economy Service Plan as low as $14.95
01/03/2018
LOS ANGELES, March 01, 2018 (GLOBE NEWSWIRE) -- GTX Corp Launches $99.00 Easy Start Plan for GPS SmartSole ® and Economy Service Plan as low as $14.95 3 new pricing models for GPS SmartSole ® and Smart Locator [...]
BriaCell To Present at Precision Breast Cancer Conference
01/03/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
Histogenics Corporation to Report 2017 Financial Results on March 15, 2018
01/03/2018
WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, [...]
ChemoCentryx to Hold Fourth Quarter 2017 Financial Results Conference Call on Friday, March 9, 2018
01/03/2018
MOUNTAIN VIEW, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced that the Company's fourth quarter 2017 financial results will be released before market open on Friday, [...]
Wildflower Quarterly Revenues Increase to $748,771
01/03/2018
VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the " Company ") is pleased to announce quarterly revenues climbed from $103,893 to $748,771. The Company experienced [...]
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results and Provides Corporate Update
01/03/2018
Cash Balance in excess of $135 million after our February 2018 follow-on financing allows for independent development of lead programs Positive Phase 1/2 Subcutaneous data for CB 2679d presented at EAHAD 2018, Phase 2b [...]
Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease Candidate
01/03/2018
TUSTIN, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
01/03/2018
FIT Biotech Oy Company release March 1, 2018 at 03:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Conformis iTotal CR Knee Replacement System Awarded “3A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
01/03/2018
BILLERICA, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a medical technology company that offers joint replacement implants designed and manufactured to fit and conform to each patient’s [...]
aTyr Pharma to Present at Two Upcoming Investor Conferences in March
01/03/2018
SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Iovance Biotherapeutics Appoints Michael Weiser, M.D., Ph.D., to its Board of Directors
01/03/2018
SAN CARLOS, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Onconova to Present Dose Optimization Studies with Rigosertib Azacitidine Combination in Patients with Myelodysplastic Syndromes at 6th International Bone Marrow Failure Disease Symposium
01/03/2018
Exploration of dose and schedule of administration in an expanded Phase 2 trial with the objective of designing a pivotal Phase 3 trial Risk-mitigation strategies to reduce the incidence of urinary tract adverse events [...]
India Globalization Capital Partners with Parkinson’s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)
01/03/2018
BETHESDA, Md., March 01, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today announces that it has signed a Joint Development and Services Agreement with the prestigious Parkinson’s [...]
Progenics Pharmaceuticals Sets Fourth Quarter and Year-End 2017 Financial Results Call for March 8
01/03/2018
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, [...]
athenahealth @ HIMSS18: Healthcare Providers, Care Staff, and Leadership Are Finally Being Freed from Administrative Burden
01/03/2018
Also: Sneak Peek Epocrates Connect, A Universal Mobile App Designed to End Industry’s Status Quo EHR Experience and Unleash Unparalleled Access to Clinical Information On Stage: CEO Jonathan Bush Hosts Thomas Jefferson [...]
scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference
01/03/2018
BURLINGTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused [...]
FDA Accepts REMOXY® NDA for Review, Sets PDUFA Date of August 7, 2018
01/03/2018
AUSTIN, Texas, March 01, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ) announced today that the U.S. Food and Drug Administration (FDA) has determined that a New Drug Application (NDA) for REMOXY ER, [...]
Spero Therapeutics to Present at March Investor Conferences
01/03/2018
CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]

Pages